Shenhao started after the college entrance examination

Faced with the proposal of Uriah, senior vice president of investment of Vanguard Capital Group, the senior vice presidents of investment of the other four major financial institutions did not think about it for too long and agreed one after another.

Andy of Merrill Lynch smiled and added, "We Merrill Lynch cannot withdraw. If we can get Amgen shares, we Merrill Lynch only hopes to get as many as possible."

Richard of Berkshire Hathaway seconded, "We Berkshire Hathaway also made the same choice. In fact, we have been paying attention to the situation of Amgen before."

"When the Amgen person started to cooperate before, we were paying close attention to the situation of Amgen." Richard added~.

"Initially we just wanted to see if there was any opportunity to target Amgen. At that time, the stock price of Amgen was only more than 150 US dollars." - Richard continued.

"With Amgen's agency sales rights for the Lighthouse Helmet and the good market feedback of the Lighthouse Helmet, the stock price of Amgen began to rise, from more than 150 US dollars to almost 180 US dollars." Richard said the details.

"Later, Amgen won the agency rights for the Guardian series of robots and obtained the recruitment quota for the second phase clinical trial of Miracle Danshen Pills, and their stock price rose again." Richard added.

"When Amgen only cooperated with Anxin Life Sciences Group to study rapamycin, their stock price rose further and has now reached the range of US$220 to US$230, fluctuating in this range." Richard said the current stock price range of Amgen Pharmaceuticals.

Barton of Morgan Investment Company shook his phone, "I have seen the latest stock price of Amgen. It is now 224.8 US dollars, and the total market value has exceeded 120 billion US dollars."

"I remember that Amgen's total market value should be less than 80 billion US dollars before?" Francis of BlackRock exclaimed, "Its market value is rising so fast!"

Uriah of Vanguard added, "If there is no accident, its stock price will rise further. This opportunity lies in when their cooperation with Anxin Life Sciences Group will produce results."

"Even if it is just a small result, just a small step forward in the progress of rapamycin research, their stock price may double." Uriah added.

"We still have the opportunity to get more shares and grab more benefits from that person." Uriah added.

"I suggest that we start today. As long as the premium does not exceed 20%, I suggest that we all take it." Uriah put forward his own opinion.

Francis from BlackRock Capital smiled and nodded, "I have no objection."

Richard from Berkshire Hathaway also agreed, "I have no objection either. We at Berkshire Hathaway are very confident that Vanguard will lead the way in such simple matters."

Andy from Merrill Lynch agreed with a smile,"I support it too."

After everyone supported the motion, Uriah did not hesitate and immediately contacted the traders under Pioneer Capital Group and assigned the corresponding tasks to them.

Currently, in the Bald Eagle stock market, the stock price of Amgen Pharmaceuticals fluctuates between $220 and $230. The current stock price is $224.65, which is a little lower than a few minutes ago.

According to the framework of 20% premium, plus a little floating adjustment, Uriah set a maximum price of $275.

However, Pioneer Capital Group is not stupid. Of course, it will not directly push the stock price of Amgen Pharmaceuticals to such a high level. They are prepared to buy slowly and control the stock price as much as possible. (To read the violent novel, go to Feilu Novel Network!)

0 Ask for flowers

The total share capital of Amgen Pharmaceuticals is 535.178.000 shares, and this total share capital has been split five times.

As early as 1990, Amgen Pharmaceuticals split its stock into two shares for every 1 share, and the following year it split its stock into three shares for every 1 share.

After two operations, the total share capital was increased to 6 times.

Subsequently, in 1995 and 1999, it split its stock into two shares for every 1 share, and finally expanded the total share capital to more than 500 million shares.

After receiving the order from Uriah, the professional traders of Pioneer Capital Group began to operate quietly, and they carefully absorbed the selling orders in the market.

Although they were careful enough, the addition of this buyer in the market was still discovered by others, so the stock price of Amgen Pharmaceuticals began to rise slowly.

From the previous $224.65 to $228.96, and this upward trend has not stopped, and it is still rising.

Even if the trader of Pioneer Capital Group slowed down the progress of the acquisition, the price went up, and there was no low-price selling order for the time being, so it naturally did not fall back.

Compared to the rise in the stock price of Amgen Pharmaceuticals in the stock market, the stock prices of traditional oil energy companies in the entire energy sector showed a downward trend.

At this moment, the Internet of Bald Eagle is full of various gossips, and these gossips are all bad news for traditional oil energy companies... Earth...